Life sciences finance teams manage long-horizon R&D investment cycles, unpredictable clinical trial costs, and regulatory approval uncertainty — requiring tools built for the unique economics of drug and device development.
Future CPM delivers specialized financial intelligence for life sciences organizations — with pre-built models, industry-specific KPIs, and integrations tailored to your operational environment.
Model research and development investment allocation across therapeutic areas, compounds, and stages with go/no-go decision support.
Build detailed clinical trial budgets by site, patient cohort, phase, and CRO contract with real-time tracking against planned spend.
Connect FDA approval milestones, regulatory timelines, and commercial launch assumptions to probability-weighted revenue forecasting.
Model commercial launch investment, market penetration curves, competitive pricing scenarios, and peak revenue projections.
Built-in support for SEC reporting, FDA financial disclosure, transfer pricing documentation, and international regulatory filing.
Connect to Veeva Vault, Medidata, and other clinical operations platforms for automated trial cost and site activation data.
From mid-market growth companies to large global enterprises — Future CPM scales to meet the complexity and ambition of any life sciences organization.
Ready to see your numbers?
Calculate Your ROI →Join life sciences finance leaders who plan smarter, close faster, and drive strategic growth with Future CPM.